Granulocyte Colony-Stimulating Factor (G-CSF) Protects Oligpdendrocyte and Promotes Hindlimb Functional Recovery after Spinal Cord Injury in Rats

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Kadota, Ryo ^a   Koda, Masao ^b   Kawabe, Junko ^a   Hashimoto, Masayuki ^c   Nishio, Yutaka ^a   Mannoji, Chikato ^b   Miyashita, Tomohiro ^a   Furuya, Takeo ^a   Okawa, Akihiko ^a   Takahashi, Kazuhisa ^a   Yamazaki, Masashi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA AOBA MUNICIPAL HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN BCL XL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DOWN REGULATION; FEMALE; HINDLIMB; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LOCOMOTION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; TREATMENT OUTCOME; UPREGULATION; WHITE MATTER INJURY;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CEREBRAL INFARCTION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1BETA; MICROSCOPY, FLUORESCENCE; MOVEMENT; MYELIN SHEATH; NEURONS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPINAL CORD; SPINAL CORD INJURIES; UP-REGULATION;

MURINAE; RATTUS;

EID: 84870287319     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050391     Document Type: Article

References (38)

1. Bauchet L, Lonjon N, Perrin FE, Gilbert C, Privat A, et al. (2009) Strategies for spinal cord repair after injury: a review of the literature and information. Ann Phys Rehabil Med 52: 230-251.
2. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS, (1997) Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3: 73-76.
3. Cao Q, Zhang YP, Iannotti C, DeVries WH, Xu XM, et al. (2005) Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp Neurol 191: S3.
4. Fehlings MG, Tator CH, (1995) The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol 132: 220-228.
5. Park E, Velumian A, Fehlings MG, (2004) The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21: 754-774.
6. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, et al. (1990) A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 17: 1405-1411.
7. Hall ED, Springer JE, (2004) Neuroprotection and acute spinal cord injury: a reappraisal. Neuro Rx 1: 80-100.
8. Nicola NA, Metcalf D, Matsumoto M, Johnson GR, (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. identification as granulocyte colony-stimulating factor. J Biol Chem 258: 9017-9023.
9. Roberts AW, (2005) G-CSF: a key regulator of neutrophil production, but that's no all! Growth Factors. 23: 33-41.
10. Jansen J Hanks S, Thompson JM, Dugan MJ, Akard LP, (2005) Transplantation of hematopoietic stem cells from the peripheral blood. J Cell Mol Med 9: 37-50.
11. Gibson CL, Bath PM, Murphy SP, (2005) G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25: 431-439.
12. Komine-Kobayashi M, Zhang N, Liu M, Tanaka R, Hara H, et al. (2006) Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 26: 402-413.
13. Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, et al. (2005) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115: 2083-2098.
14. Shäbitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, et al. (2003) Neuroprotective effect of granulocyte colony-stimulating factorafter focal cerebral ischemia. Stroke 34: 745-751.
15. Six I, Gasan G, Mura E, Bordet R, (2003) Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacol 458: 327-328.
16. Shyu WC, Lin SZ, Lee CC, Liu DD, Li H, (2006) Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ 174: 927-933.
17. Kawabe J, Koda M, Hashimoto M, Fujiyoshi T, Furuya T, et al. (2011) Neuroprotective effects of granulocyte colony-stimulating factor and relationship to promotion of angiogenesis after spinal cord injury in rats. J Neurosurg Spine in press.
18. Koda M, Nishio Y, Kamada T, Someya Y, Okawa A, et al. (2007) Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res 1149: 223-231.
19. Nishio Y, Koda M, Kamada T, Someya Y, Kadota R, et al. (2007) Granulocyte colony-stimulating factor (G-CSF) attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol 66: 724-731.
20. Osada T, Watanabe M, Hasuo A, Imai M, Suyama K, (2010) Efficacy of the coadministration of granulocyte colony-stimulating factor and stem cell factor in the activation of intrinsic cells after spinal cord injury in mice. J Neurosurg Spine 13: 516-523.
21. Pitzer C, Klussmann S, Krüger C, Letellier E, Plaas C, et al. (2010) The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury. J Neurochem 113: 930-942.
22. Sanli AM, Serbes G, Calişkan M, Kaptanoǧlu E, Sargon MF, et al. (2010) Effect of granulocyte-colony stimulating factor on spinal cord tissue after experimental contusion injury. J Clin Neurosci 17: 1548-1552.
23. Loddick SA, Rothwell NJ, (1996) Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal ischemia in the rat. J Cereb Blood Flow Metab 16: 932-940.
24. Zavala F, Abad S, Ezine S, Taupin V, Masson A, et al. (2002) G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J Immunol 168: 2011-2019.
25. Boneberg EM, Hareng L, Gantner F, Wendel A, Hartung T, (2000) Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon γ. Blood 95: 270-276.
26. Nishiki S, Hato F, Kamata N, Sakamoto E, Hasegawa T, et al. (2004) Selective activation of STAT 3 in human monocytes stimulated by G-CSF: implication in inhibition of LPS-induced TNF-α production. Am J Physiol Cell Physiol 286: 1302-1311.
27. Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, et al. (1997) The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury. Br J Pharmacol 120: 333-339.
28. Lee S, Chu K, Jung K, Ko SY, Kim EH, et al. (2005) Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 1058: 120-128.
29. Takahashi JL, Giuliani F, Power C, Imai Y, Yong VW, (2003) Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol 53: 588-595.
30. Lee YB, Yune TY, Baik SY, Shin YH, Du S, et al. (2000) Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury. Exp Neurol 166: 190-195.
31. Barres BA, Jacobson MD, Schmid R, Sendtner M, Raff MC, (1993) Does oligodendrocyte survival depend on axons? Current Biol 3: 489-497.
32. Blight AR, (1983) Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling. Neuroscience 10: 521-543.
33. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR, (2004) Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4: 451-464.
34. Jung K, Chu K, Lee ST, Kim SJ, Sinn DL, et al. (2006) Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation. Brain Res 1074: 190-201.
35. Stroke Therapy Academic Industry Roundtable (STAIR) (1990) Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development. Stroke 30: 2752-2758.
36. Schneider A, Wysocki R, Pitzer C, Krüger C, Laage R, et al. (2006) An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol 4: 36.
37. Basso DM, Beattie MS, Bresnahan JC, (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12: 1-21.
38. Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, et al. (2002) Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 99: 3024-3029.